NASDAQ: LIPOLipella Pharmaceuticals Inc Stock Ownership - Who owns Lipella Pharmaceuticals?
Insider buying vs selling
Have Lipella Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jonathan H. Kaufman | Director | 2024-05-14 | 10,000 | $0.76 | $7.59kBuy |
LIPO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LIPO insiders and whales buy or sell their stock.
LIPO Shareholders
What type of owners hold Lipella Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jonathan H. Kaufman | 35.27% | 898,849 | $2.16M | Insider |
| Michael B. Chancellor | 34.43% | 877,637 | $2.11M | Insider |
| Virtu Financial LLC | 0.52% | 13,310 | $31.94k | Institution |
| Mai Capital Management | 0.00% | 125 | $300.00 | Institution |
| Bank Of America Corp | 0.00% | 7 | $16.80 | Institution |
| Concourse Financial Group Securities Inc | 0.00% | 0 | $0.00 | Institution |
LIPO vs Biotech Stocks
Lipella Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.